Palacio, Merry Crist L.

HRN: 06-62-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2025
CEFUROXIME 1.5GM (VIAL)
05/12/2025
05/13/2025
IVT
1.5g
Q8
S/P Primary LTCS
Waiting Final Action 
05/12/2025
CEFUROXIME 500MG (TAB)
05/12/2025
05/19/2025
PO
500mg
BID
S/P Primary LTCS
Waiting Final Action 
05/12/2025
METRONIDAZOLE 500MG (TAB)
05/12/2025
05/19/2025
PO
500mg
TID
S/P LTCS
Waiting Final Action 
05/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/12/2025
05/13/2025
IVT
500mg
Q8
S/P Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: